Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

preview_player
Показать описание

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

© 2018 NACCME, an HMP Company
Рекомендации по теме